Clinical Trials Logo
  1. Home
  2. Blood Coagulation Disorders
  3. NCT00964353

Clinical and Economic Implications of Genetic Testing for Warfarin Management

Blood Coagulation Disorders Clinical Trial

Official title:
The Hospital and Economics CERT: Project 1: The Clinical and Economic Implications of Genetic Testing for Warfarin Management

Clinical Trial Summary

The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether providing doctors with data on the genes their patients inherited and warfarin dosing recommendations based on those genes affects the costs and outcomes of care and after hospitalization for patients from different ethnic/racial backgrounds, and how physicians use this information in decision making.

Clinical Trial Description

The overall goal of this project is to develop and assess the effectiveness and cost-effectiveness of strategies that use genetic testing in the management of anticoagulation among racially diverse hospitalized patients. The project has four specific aims.

Aim 1: To contribute patients initiating therapy at the University of Chicago Medical Center (UCMC) and affiliated hospitals to a genetic registry of a racially diverse set of patients undergoing warfarin therapy.

Aim 2: To perform a randomized trial to determine the efficacy, costs and cost-effectiveness of existing pharmacogenetic algorithms for the management of warfarin therapy among hospitalized patients of all races.

Aim 3: To develop clinical pharmacogenetic algorithms for the management of warfarin therapy among hospitalized African American patients.

Aim 4: To perform a randomized trial to determine and compare the efficacy, costs and cost-effectiveness of existing clinical and non-racially tailored pharmacogenetic algorithms to racially tailored pharmacogenetic algorithms for the management of warfarin therapy among hospitalized African American patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00964353
Study type Interventional
Source University of Chicago
Contact
Status Completed
Phase Phase 4
Start date August 2009
Completion date April 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02239991 - Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant N/A
Completed NCT01435304 - The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass N/A
Completed NCT00969319 - Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America N/A
Completed NCT00091494 - Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA N/A
Completed NCT00005481 - Epidemiology of Impaired Coagulant Balance in Diabetes N/A
Recruiting NCT02379104 - ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals N/A
Withdrawn NCT02774317 - Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months Phase 4
Recruiting NCT01930916 - Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients N/A
Completed NCT00168090 - Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) Phase 4
Completed NCT01787552 - A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF Phase 1/Phase 2
Not yet recruiting NCT02782338 - The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin N/A
Unknown status NCT01349712 - Study to Test the Accuracy of a Prototype Handheld PT/INR Device N/A
Completed NCT01143909 - Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients N/A
Recruiting NCT04762550 - Thrombin Generation in Liver Transplant Surgery
Withdrawn NCT01221389 - Study Using Plasma for Patients Requiring Emergency Surgery Phase 4
Withdrawn NCT00233246 - Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures Phase 3
Recruiting NCT03884725 - Fibrinogen Concentrate In Children Cardiac Surgery 2 Phase 4
Completed NCT00086476 - Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles N/A
Completed NCT00516126 - Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery Phase 4
Completed NCT00708435 - Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy Phase 3